Consistent with this, other studies found LOXL2 protein levels to be higher in poorly differentiated breast carcinomas, and elevated LOXL2 mRNA was observed in invasive and metastatic breast cancer cell lines [5,6]. This evidence concerns the gene LOXL2 and breast carcinoma.